Antiviral iridoid glycosides from Clerodendrum myricoides

Fitoterapia. 2021 Nov:155:105055. doi: 10.1016/j.fitote.2021.105055. Epub 2021 Oct 6.

Abstract

The methanol root extract of Clerodendrum myricoides (Hochst.) Vatke afforded two new (1, 2) and two known (3, 4) iridoid glycosides. The structures of the isolated compounds were established based on NMR, IR, UV and MS data analyses. The crude extract and the isolated constituents were assayed for antiviral activity against the human respiratory syncytial virus (RSV) in human laryngeal epidermoid carcinoma (HEp-2) cells. The crude extract inhibited RSV infectivity at EC50 = 0.21 μg/ml, while it showed cytotoxicity against HEp-2 cells with CC50 = 9 μg/ml. Compound 2 showed 43.2% virus inhibition at 100 μM, while compounds 1 as well as 3 and 4 had only weak antiviral and cytotoxic activities.

Keywords: Antiviral activity; Clerodendrum myricoides; Iridoid glycosides; Lamiaceae; RSV inhibitor.

MeSH terms

  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology*
  • Cell Line, Tumor
  • Clerodendrum / chemistry*
  • Humans
  • Iridoid Glycosides / isolation & purification
  • Iridoid Glycosides / pharmacology*
  • Molecular Structure
  • Phytochemicals / isolation & purification
  • Phytochemicals / pharmacology
  • Plant Extracts
  • Plant Roots / chemistry
  • Respiratory Syncytial Virus, Human / drug effects*
  • Rwanda

Substances

  • Antiviral Agents
  • Iridoid Glycosides
  • Phytochemicals
  • Plant Extracts